Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations
- PMID: 36756145
- PMCID: PMC9899899
- DOI: 10.3389/fphar.2022.1054575
Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations
Abstract
Gastrin plays important role in stimulating the initiation and development of many gastrointestinal diseases through interacting with the cholecystokinin 2 receptor (CCK2R). The smallest bioactive unit of gastrin activating CCK2R is the C-terminal tetrapeptide capped with an indispensable amide end. Understanding the mechanism of this smallest bioactive unit interacting with CCK2R on a molecular basis could provide significant insights for designing CCK2R antagonists, which can be used to treat gastrin-related diseases. To this end, we performed extensive Gaussian accelerated molecular dynamics simulations to investigate the interaction between gastrin C-terminal pentapeptide capped with/without amide end and CCK2R. The amide cap influences the binding modes of the pentapeptide with CCK2R by weakening the electrostatic attractions between the C-terminus of the pentapeptide and basic residues near the extracellular domain in CCK2R. The C-terminus with the amide cap penetrates into the transmembrane domain of CCK2R while floating at the extracellular domain without the amide cap. Different binding modes induced different conformational dynamics of CCK2R. Residue pairs in CCK2R had stronger correlated motions when binding with the amidated pentapeptide. Key residues and interactions important for CCK2R binding with the amidated pentagastrin were also identified. Our results provide molecular insights into the determinants of the bioactive unit of gastrin activating CCK2R, which would be of great help for the design of CCK2R antagonists.
Keywords: GAMD; MM-PBSA analysis; PMF; cholecystokinin 2 receptor; gastrin; interaction mechanism.
Copyright © 2023 Yang, Jin, Gao, Wang and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells.Cell Signal. 2005 Dec;17(12):1505-15. doi: 10.1016/j.cellsig.2005.03.009. Cell Signal. 2005. PMID: 15951156
-
Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.J Biol Chem. 2011 Feb 25;286(8):6707-19. doi: 10.1074/jbc.M110.196048. Epub 2010 Dec 14. J Biol Chem. 2011. PMID: 21156802 Free PMC article.
-
Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor.J Biol Chem. 2007 Sep 28;282(39):28779-28790. doi: 10.1074/jbc.M700349200. Epub 2007 Jun 28. J Biol Chem. 2007. PMID: 17599907
-
Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.Q J Nucl Med Mol Imaging. 2015 Sep;59(3):287-302. Epub 2015 Jul 9. Q J Nucl Med Mol Imaging. 2015. PMID: 26158215 Review.
-
Biology of gut cholecystokinin and gastrin receptors.Clin Exp Pharmacol Physiol. 1997 Mar-Apr;24(3-4):209-16. doi: 10.1111/j.1440-1681.1997.tb01809.x. Clin Exp Pharmacol Physiol. 1997. PMID: 9131287 Review.
Cited by
-
A multi-omics exploration of PPARG activation in colon cancer: kinases featuring a PPRE sequence within regulatory regions.Biol Direct. 2025 Jun 11;20(1):68. doi: 10.1186/s13062-025-00654-7. Biol Direct. 2025. PMID: 40500799 Free PMC article.
-
Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 via Network Pharmacology, Computational Biology, and Surface Plasmon Resonance Verification.Curr Comput Aided Drug Des. 2024;20(7):1113-1129. doi: 10.2174/0115734099272592231004170422. Curr Comput Aided Drug Des. 2024. PMID: 37855353
-
The role of redox signaling in mitochondria and endoplasmic reticulum regulation in kidney diseases.Arch Toxicol. 2025 May;99(5):1865-1891. doi: 10.1007/s00204-025-04041-z. Epub 2025 Apr 11. Arch Toxicol. 2025. PMID: 40214774 Free PMC article. Review.
References
-
- Bläker M., Ren Y., Seshadri L., McBride E. W., Beinborn M., Kopin A. S. (2000). CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides. Mol. Pharmacol. 58 (2), 399–406. 10.1124/mol.58.2.399 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous